Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate TransMedics Group Inc before investing.

In this article, we go over a few key elements for understanding TransMedics Group Inc’s stock price such as:

• TransMedics Group Inc’s current stock price and volume
• Why TransMedics Group Inc’s stock price changed recently
• Upgrades and downgrades for TMDX from analysts
• TMDX’s stock price momentum as measured by its relative strength

About TransMedics Group Inc (TMDX)

Before we jump into TransMedics Group Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Want to learn more about TransMedics Group Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about TransMedics Group Inc.

TransMedics Group Inc’s Stock Price as of Market Close

As of September 11, 2024, 4:00 PM, CST, TransMedics Group Inc’s stock price was $143.81.

TransMedics Group Inc is up 5.99% from its previous closing price of $135.68.

During the last market session, TransMedics Group Inc’s stock traded between $133.36 and $140.63. Currently, there are 33.12 million shares of TransMedics Group Inc stock available for purchase.

Unfortunately, TransMedics Group Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

TransMedics Group Inc Stock Price History

TransMedics Group Inc’s (TMDX) price is currently down 14.43% so far this month.

During the month of September, TransMedics Group Inc’s stock price has reached a high of $166.79 and a low of $133.36.

Over the last year, TransMedics Group Inc has hit prices as high as $177.37 and as low as $36.42. Year to date, TransMedics Group Inc’s stock is up 133%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused TransMedics Group Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 10, 2024, there were 0 analysts who downgraded TransMedics Group Inc’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate TransMedics Group Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on TransMedics Group Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

TransMedics Group Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about TransMedics Group Inc (TMDX) by visiting AAII Stock Evaluator.

Relative Price Strength of TransMedics Group Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 10, 2024, TransMedics Group Inc has a weighted four-quarter relative price strength of 14.35%, which translates to a Momentum Score of 91 and is considered to be Very Strong.

Want to learn more about how TransMedics Group Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

TransMedics Group Inc Stock Price: Bottom Line

As of September 11, 2024, TransMedics Group Inc’s stock price is $143.81, which is up 5.99% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like TransMedics Group Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.